AFP and hepatocellular carcinoma: Circulating lncRNA HULC (highly upregulated in liver cancer) and Linc00152 were significantly upregulated in the plasma of patients with hepatocellular carcinoma, and a combination of the two lncRNAs improved the diagnostic accuracy of alpha-fetoprotein, a biomarker for hepatocellular carcinoma diagnosis for patients [17].